Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma
MS Meuleman, A Duval, A Grunenwald, MR Artero… - Clinica Chimica …, 2024 - Elsevier
Introduction The complement system is involved in numerous diseases, through diverse
mechanisms and degree of activation. With the emergence of complement targeting …
mechanisms and degree of activation. With the emergence of complement targeting …
Complement involvement in sickle cell disease
MS Meuleman, LT Roumenina, A Grunenwald - La Presse Médicale, 2023 - Elsevier
Abstract Sickle Cell Disease (SCD) is a hereditary blood disorder characterized by the
presence of abnormal hemoglobin, leading to the formation of sickle-shaped red blood cells …
presence of abnormal hemoglobin, leading to the formation of sickle-shaped red blood cells …
[HTML][HTML] Formation of Multinucleated Giant Cells after Experimental Intracerebral Hemorrhage: Characteristics and Role of Complement C3
X Fu, M Wang, Y Wan, Y Hua, RF Keep, G Xi - Biomedicines, 2024 - mdpi.com
Hematoma clearance is critical for mitigating intracerebral hemorrhage (ICH)-induced brain
injury. Multinucleated giant cells (MGCs), a type of phagocyte, and the complement system …
injury. Multinucleated giant cells (MGCs), a type of phagocyte, and the complement system …
Spatially resolved transcriptomic profiling for glomerular and tubulointerstitial gene expression in C3 glomerulopathy
JH Koh, M Kang, S Park, JM Cho, S Cho, Y Kim, S Lee… - medRxiv, 2023 - medrxiv.org
Introduction: C3 glomerulopathy (C3G) is a rare but clinically significant glomerulopathy.
However, little is known about its transcriptomic profile. We investigated the substructure …
However, little is known about its transcriptomic profile. We investigated the substructure …
[引用][C] Recent developments in C3-targeted complement therapeutics
DC Mastellos, JD Lambris - Seminars in immunology, 2022 - pubmed.ncbi.nlm.nih.gov
Recent developments in C3-targeted complement therapeutics Recent developments in C3-targeted
complement therapeutics Semin Immunol. 2022 Mar:60:101645. doi: 10.1016/j.smim.2022.101645 …
complement therapeutics Semin Immunol. 2022 Mar:60:101645. doi: 10.1016/j.smim.2022.101645 …